The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus-Reference-Cited by-同舟云学术

The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus

Published:2011-09-28 Issue:2 Volume:37 Page:364-377
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Hradetzky Eva,Sanderson Thomas M,Tsang Tsz M,Sherwood John L,Fitzjohn Stephen M,Lakics Viktor,Malik Nadia,Schoeffmann Stephanie,O'Neill Michael J,Cheng Tammy MK,Harris Laura W,Rahmoune Hassan,Guest Paul C,Sher Emanuele,Collingridge Graham L,Holmes Elaine,Tricklebank Mark D,Bahn Sabine

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp2011219.pdf

Reference71 articles.

1. Anderson WW, Collingridge GL (2001). The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J Neurosci Methods 108: 71–83.

2. Andreasen M, Lambert JD, Jensen MS (1989). Effects of new non-N-methyl-D-aspartate antagonists on synaptic transmission in the in vitro rat hippocampus. J Physiol 414: 317–336.

3. Bayer SA, Altman J, Russo RJ, Zhang X (1993). Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14: 83–144.

4. Benes FM, Sorensen I, Bird ED (1991). Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 17: 597–608.

5. Benjamini J, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Series B (Methodological) 57: 289–300.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia;Biochemical Pharmacology;2024-05

2. Pharmacological animal models of schizophrenia for antipsychotic drug discovery and development;Journal of Volgograd State Medical University;2023-07-30

3. The MAM Model to Study the Role of Dopamine in Schizophrenia;Dopaminergic System Function and Dysfunction: Experimental Approaches;2022-12-08

4. The Antioxidant N-Acetyl-L-Cysteine Restores the Behavioral Deficits in a Neurodevelopmental Model of Schizophrenia Through a Mechanism That Involves Nitric Oxide;Frontiers in Pharmacology;2022-07-12

5. Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models;International Journal of Molecular Sciences;2022-05-13